Tirzepatide weight loss treatment works by activating both GLP-1 and GIP receptors, helping to control cravings, slow digestion, and improve insulin sensitivity
If weight loss alone doesn't explain the benefit, inflammation may play an important role
Further research is needed to improve our understanding of their effects on obesity-related comorbidities and the underlying mechanism, whether involving direct effects on target tissues or mediated by improvement in BW, glucose levels and other CV risk factors
Hyperuricemia exacerbates oxidative stress, thereby intensifying inflammation and endothelial dysfunction within this context
The protein that results from the use of the downstream UGA stop codon, due to readthrough translation, is identified as VDRAx
103 WangB.WangH.YangZ